Cardiac AI: Peer Review vs. Vendor Projection for Investors
In the world of cardiovascular AI, vendors love to make big promises about health outcomes and cost savings.…
Cardiac AI: Decoding “Advisory Forum” Claims for Investors
Cardiac AI is completely changing diagnostics and patient management, but that means clinical evaluators and procurement teams have…
Zio Watch: AI’s Path to a Billion Dollar Afib Market
The idea of getting real medical data from a watch has been around forever, a holy grail for…
Heart Patch AI: Unlocking Billions in Silent AFib Prevention
The real impact of artificial intelligence on cardiovascular health isn’t just about better predictions. It’s about changing how…
Cardiac AI’s Form Factor Frontier: De-Risking Your Investment
The cardiovascular AI diagnostics field is exploding, throwing a lot of new tech at clinicians, buyers, and investors.…
The Paper Still Defining AI ECG Diagnosis
You see a lot of noise about AI in cardiology, new clearances, big funding rounds, promises of changing…
Eko’s EFAST: The Future of Cardiovascular AI Investment
The whole field of cardiovascular AI is shifting. We’re finally moving past narrow algorithms built for one specific…
The Silent Epidemic: Why AFib Stays Hidden Until Stroke
Atrial fibrillation (AFib) is the most common arrhythmia we deal with, and it’s a total paradox. It dramatically…
Cadence HypertensionOS: De-Risking AI for Billions in Cardiac Health
The whole field of cardiovascular AI is splitting into two camps. You’ve got your generalized, consumer-facing apps, and…
FDA TEMPO Pilot: De-Risking Digital Health for Investors
There’s a constant tug-of-war in digital health, especially in cardiology: tech moves at light speed, but clinical validation…